A Higher Bar For Expert Witnesses In Drug Patent Litigation
Hatch-Waxman litigation remains a driving force in pharmaceutical patent disputes, with abbreviated new drug application cases shaping competition between brand and generic-drug manufacturers....To view the full article, register now.
Already a subscriber? Click here to view full article